Replies to post #197030 on Amarin Corp Plc (AMRN)

[Biobillionair]

Cards:

If anyone on medicare wants Vascepa for good price switch your plan to medicare silverscripts.

Good advice. When G argues just ignore him, he’s not a clinical provider.

BB

[sts66]

Medicare Silverscrips is way more expensive in my state than Humana - they currently offer 3 levels of plans costing $30, $69, and $93/mo, V on T4 on all of them, copays are $150, $122, and $117 - that's no bargain, the monthly premium wipes out any savings on V. I believe pricing may be different in FL, but again could depend on what plan you pay for.

[ilovetech]

Cardio,

Based on the feedback from the board, it's safe to say Medicare Part D sucks across markets for V coverage.

-IMO, the administrative bureaucracy has failed miserably to advise plan holders that they have choices. Add in that Seniors are apt to stay as is, so I wouldn't hold my breath that these realities will change.

-None of this will matter once we get the label expansion.

ILT

[HDGabor]

You obviously have no experience how prescribing to real patients work and what factors influence whether patients fill prescriptions or not.

Yes, you are right … but I did not say otherwise. (Furthermore, I did not post / opine in this area … in any area where I do not have knowledge … unlike you.) However it not the topic … just a reminder: it is the "coverage"

All Vascepa reps have extensive knowledge which insurances cover well and which ones don’t. They are there on the ground.

His 90 percent lives covered is bs that he has to promote to amarin investors.

You obviously have no experience top of how prescribing to real patients work and what factors influence whether patients fill prescriptions or not … your view does not make any sense

- if it is a bs … it is a law / SEC violation … but it isn't a bs
- unless they would like to raise additional cash - which is not likely - the daily pps / investors' opinion has 0.00% effect on the company … he does not have to promote the coverage …
-acc. to my best knowledge the Managed Markets Insight & Technology, LLC is independent from Amarin … says (Medicare): 96% Covered (inc. 18% Preferred) and 4% Not Covered by the 1,476 Medicare plans … and 95% have Unrestricted Access. [Part D plans: app. 44 million … 15% of the US]